Transcriptome sequencing and single-cell sequencing analysis identify GARS1 as a potential prognostic and immunotherapeutic biomarker for multiple cancers, including bladder cancer

BackgroundGlycyl-tRNA synthetase 1 (GARS1) belongs to the aminoacyl-tRNA synthetase family, playing a crucial role in protein synthesis. Previous studies have reported a close association between GARS1 and various tumors. However, the role of GARS1 in human cancer prognosis and its impact on immunol...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jianqiang Nie, Taobin Liu, Taotao Mao, Hailang Yang, Wen Deng, Xiaoqiang Liu, Bin Fu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2023-06-01
Edice:	Frontiers in Immunology
Témata:	GARS1 pan-cancer prognosis biomarkers immunotherapeutic bladder cancer
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1169588/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!